NEW YORK — The US Food and Drug Administration this week granted separate Emergency Use Authorizations for PCR-based SARS-CoV-2 tests developed by Quadrant Biosciences and KimForest Enterprise.
Quadrant's Clarifi COVID-19 Test Kit is designed to detect two sequences of the SARS-CoV-2 RdRp gene in saliva swab specimens collected by a healthcare provider using DNA Genotek's ORACollect RNA kit.